Duloxetine and hyponatremia: A report of 5 cases [10]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 1, 2007, Pages 101-104

  Krüger, Stephanie ^a   Lindstaedt, Michael ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; DULOXETINE; LORAZEPAM; QUETIAPINE; SODIUM CHLORIDE; ZOPICLONE;

APPETITE; CONSTIPATION; DIZZINESS; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; FATIGUE; HUMAN; HYPONATREMIA; LETHARGY; LETTER; MAJOR DEPRESSION; MUSCLE WEAKNESS; NAUSEA; NEUROPATHIC PAIN; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SIDE EFFECT; SOMNOLENCE; STRESS INCONTINENCE; SWEATING; WATER DEPRIVATION; XEROSTOMIA;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYPONATREMIA; MALE; MIDDLE AGED; THIOPHENES;

EID: 33846215883     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31802e688a     Document Type: Letter

References (12)

1. Westanmo AD, Gayken J, Haight R. Duloxetine: a balanced and selective norepinephrine-and serotonin-reuptake inhibitor. Am J Health Syst Pharm. 2005;62(23):2481-2490.
2. Detke M, Lu Y, Goldstein DJ, et al. Duloxetine, 60 mg once daily for major depressive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2002;63:308-315.
3. Nemeroff CB, Schatzberg AF, Goldstein DJ, et al. Duloxetine for the treatment of major depressive disorder. Gen Psychopharmacol. 2002;36(4106):132.
4. Mallinckrodt C, Prakash A, Andom AC, et al. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range. J Psychiatr Res. 2006;40(4):337-348.
5. Assal F, Chauchot F. Hyponatremia of therapeutic origin. Apropos of a case. Encephale. 1994;20(5):527-529.
6. Movig KL, Leufkens HG, Lenderink AW, et al. Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly. Eur J Clin Pharmacol. 2002;58(2):143-148.
7. Movig KL, Leufkens HG, Lenderink AW, et al. Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol. 2002;53(4):363-369.
8. Madhusoodanan S, Bogunovic OJ, Moise D, et al. Hyponatraemia associated with psychotropic medications. A review of the literature and spontaneous reports. Adverse Drug React Toxicol Rev. 2002;21(1-2):17-29.
9. Adrogue HJ. Consequences of inadequate management of hyponatremia. Am J Nephrol. 2005;25(3):240-249.
10. Leung VP, Chiu HF, Lam LC. Hyponatremia associated with paroxetine. Pharmacopsychiatry. 1998;31(1):32-34.
11. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581-1589.
12. Berl T. Treating hyponatremia: damned if we do and damned if we don't. Kidney Int. 1990;37(3):1006-1018.